Growth Metrics

RemSleep Holdings (RMSL) Shares Outstanding (Weighted Average) (2010 - 2025)

RemSleep Holdings recorded quarterly Shares Outstanding (Weighted Average) of $1.6 billion in Q4 2025, up 1.2% quarter-over-quarter from $1.5 billion in Q3 2025, and up 6.18% year-over-year from $1.5 billion in Q4 2024.

RemSleep Holdings' Shares Outstanding (Weighted Average) history runs 16 years deep, the most recent figure standing at $1.6 billion for Q4 2025.

  • In Q4 2025, Shares Outstanding (Weighted Average) rose 6.18% year-over-year to $1.6 billion; the TTM figure through Dec 2025 stood at $1.6 billion (up 6.18% YoY), while the FY2025 annual figure was $1.6 billion, up 6.18% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $1.6 billion for Q4 2025 at RemSleep Holdings, up from $1.5 billion in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.6 billion in Q4 2025 to a low of $407.0 million in Q1 2021.
  • A 5-year average of $1.3 billion and a median of $1.5 billion in 2023 frame the typical range for Shares Outstanding (Weighted Average).
  • Across the five-year window, Shares Outstanding (Weighted Average) surged 2724.52% in 2021 and decreased 0.02% in 2023, its largest moves.
  • RemSleep Holdings' Shares Outstanding (Weighted Average) stood at $700.9 million in 2021, then jumped by 108.59% to $1.5 billion in 2022, then slipped by 0.02% to $1.5 billion in 2023, then gained by 1.02% to $1.5 billion in 2024, then advanced by 6.18% to $1.6 billion in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $1.6 billion, $1.5 billion, and $1.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.74 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 382.90 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 579.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 385.10 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 456.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 98.20 Mn
10 RemSleep Holdings - - -7,636.00 1.57 Bn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.57 Bn
Sep 30, 2025 1.55 Bn
Jun 30, 2025 1.54 Bn
Mar 31, 2025 1.53 Bn
Dec 31, 2024 1.48 Bn
Sep 30, 2024 1.51 Bn
Jun 30, 2024 1.47 Bn
Mar 31, 2024 1.46 Bn
Dec 31, 2023 1.46 Bn
Sep 30, 2023 1.46 Bn
Jun 30, 2023 1.46 Bn
Mar 31, 2023 1.46 Bn
Dec 31, 2022 1.46 Bn
Sep 30, 2022 1.44 Bn
Jun 30, 2022 1.42 Bn
Mar 31, 2022 1.38 Bn
Dec 31, 2021 700.90 Mn
Sep 30, 2021 569.84 Mn
Jun 30, 2021 469.68 Mn
Mar 31, 2021 406.97 Mn
Dec 31, 2020 215.67 Mn
Sep 30, 2020 226.19 Mn
Jun 30, 2020 16.63 Mn
Mar 31, 2020 149.58 Mn
Dec 31, 2019 45.42 Mn
Sep 30, 2019 68.38 Mn
Jun 30, 2019 20.99 Mn
Mar 31, 2019 4.74 Mn
Dec 31, 2018 4.07 Mn
Sep 30, 2018 5.97 Mn
Jun 30, 2018 5.76 Mn
Mar 31, 2018 3.68 Mn
Dec 31, 2017 3.39 Mn
Sep 30, 2017 3.45 Mn
Jun 30, 2017 3.25 Mn
Mar 31, 2017 3.29 Mn
Dec 31, 2016 3.26 Mn
Sep 30, 2016 16,762.00
Jun 30, 2016 3.26 Mn
Mar 31, 2016 61.10 Mn
Dec 31, 2015 60.88 Mn
Sep 30, 2015 173,940.00
Jun 30, 2015 173,940.00
Mar 31, 2015 173,940.00
Dec 31, 2014 60.75 Mn
Sep 30, 2014 173,940.00
Jun 30, 2014 173,940.00
Mar 31, 2014 171,970.00
Dec 31, 2013 171,970.00
Sep 30, 2013 344.88 Mn
Jun 30, 2013 344.16 Mn
Mar 31, 2013 341.80 Mn
Dec 31, 2012 320.18 Mn
Sep 30, 2012 307.11 Mn
Jun 30, 2012 298.64 Mn
Mar 31, 2012 298.64 Mn
Dec 31, 2011 176.58 Mn
Sep 30, 2011 163.64 Mn
Jun 30, 2011 163.64 Mn
Mar 31, 2011 163.94 Mn
Dec 31, 2010 83.14 Mn